Assessing the Impact of Heart Failure Therapeutics on Quality of Life and Functional Capacity
- 28 April 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Current Treatment Options in Cardiovascular Medicine
- Vol. 15 (4), 425-436
- https://doi.org/10.1007/s11936-013-0249-2
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Heart Disease and Stroke Statistics—2012 UpdateCirculation, 2012
- Tai Chi Exercise in Patients With Chronic Heart FailureArchives of Internal Medicine, 2011
- Darbepoetin Alfa Impact on Health Status in Diabetes Patients with Kidney DiseaseClinical Journal of the American Society of Nephrology, 2011
- Eplerenone in Patients with Systolic Heart Failure and Mild SymptomsNew England Journal of Medicine, 2011
- Safety and Efficacy of Sertraline for Depression in Patients With Heart Failure: Results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) TrialJournal of the American College of Cardiology, 2010
- Exercise training for systolic heart failure: Cochrane systematic review and meta‐analysisEuropean Journal of Heart Failure, 2010
- Effects of Exercise Training on Health Status in Patients With Chronic Heart FailureJAMA, 2009
- Efficacy and Safety of Exercise Training in Patients With Chronic Heart FailureJAMA, 2009
- Quality of life and economic outcomes with surgical ventricular reconstruction in ischemic heart failure: Results from the Surgical Treatment for Ischemic Heart Failure trialAmerican Heart Journal, 2009
- Spiritual Well-Being and Depression in Patients with Heart FailureJournal of General Internal Medicine, 2007